Biographies

Victor P. Berardi

CEO and SENIOR SCIENTIST, formerly Chief of Virology at the Massachusetts State Laboratory Institute, Department of Public Health. Victor has pioneered in the development of antibody capture EIA's, OspA-free testing for Lyme disease and Lyme vaccine exposure, and the use of recombinant antigens and PCR in the diagnosis of HGE. He is past Chairman, Clinical Virology, Northeast Association for Clinical Microbiology and Infectious Diseases, and is widely published in the area of laboratory diagnosis of all of the tick-borne diseases.

Patricia Devine, M.D.

LABORATORY MEDICAL DIRECTOR, who is board certified in anatomic and clinical pathology and in medical microbiology by the American Board of Pathology. She completed a fellowship in blood bank/ transfusion medicine. Patricia is a practicing physician. She is active in national pathology and laboratory professional organizations and has published in laboratory medical journals. She has also served as an assistant and associate director at IMUGEN for over ten years.

Philip J. Molloy, M.D.

MEDICAL DIRECTOR, Rheumatologist in private practice in a highly endemic area for Lyme disease. Dr. Molloy is a member of the Massachusetts Department of Public Health's Lyme Disease Advisory Committee, and the co-author of many publications on the serologic and immunologic characterization of Lyme arthritis patients. He is actively involved in the research on the correlation of clinical features and laboratory findings in patients with various manifestations and stages of Lyme infection.

David H. Persing, M.D., Ph.D

DIRECTOR OF LABORATORY SCIENCE, also serves as Executive Vice President and the Chief Medical and Technology Officer of Cepheid, Sunnyvale, CA. David is formerly a Vice President and the Medical Director of the Infectious Disease Research Institute of Corixa Corporation; as well as, formerly an Associate Director of Laboratory Medicine and Pathology, Mayo Medical School. He is the author of numerous publications on diagnosing various infectious diseases. David has served on the editorial boards of the Journal of Clinical Microbiology, Diagnostic Microbiology and Infectious Diseases, Journal of Infectious Diseases, Emerging Infectious Diseases, New England Journal of Medicine, and Gastroenterology. He also served on the IDSA Practice Guidelines Committee on Lyme Disease.

Mary Ellen Hewins, Karen Weeks

LABORATORY MANAGERS, have devoted the past 20 years to specialized serologic and molecular diagnostic test development for tick-borne infections, and serve as Corporate Vice Presidents of IMUGEN. They have pioneered in the development of capture EIA's, Western Blot tests, OspA-free test reagents, recombinant HGA test antigens, and PCR, and have published on test refinements for tick-borne diseases in peer reviewed journals.

IMUGEN Publications

To view publications from IMUGEN staff, please download the IMUGEN Bibliography.